As of January 22, 2025, Equillium (EQ) has a market cap of $22.676 million USD. According to our data, Equillium is ranked No.8561 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $22.68 M |
-14.67%
|
Dec 31, 2024 | $26.57 M |
4.17%
|
Dec 29, 2023 | $25.51 M |
-32.08%
|
Dec 30, 2022 | $37.56 M |
-71.88%
|
Dec 31, 2021 | $0.13 B |
-29.53%
|
Dec 31, 2020 | $0.19 B |
58.28%
|
Dec 31, 2019 | $0.12 B |
-58.58%
|
Dec 31, 2018 | $0.29 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Market Cap | = | EQ Stock Price | * | EQ Shares Outstanding |
= | $0.64 | * | 35.43 M | |
= | $22.68 M |